One of the genes affecting both cytoskeleton and GBM is WW domain-containing oxidoreductase (WWOX), a haploinsufficient tumor suppressor described in many cancers, including GBM, for which it impairs malignant phenotype [17]. Here, WWOX is linked to neoplasm.